© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
May 09, 2022
Patients are at risk for developing severe dry eye and ocular surface disease.
May 02, 2022
During a presentation at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Yuichi Hori, MD, PhD, and colleagues found that taping the top border of a surgical mask to a clinicians’ skin reduces the potential for ocular surface damage resulting from expirations of air reaching the ocular surface during the COVID-19 pandemic.
April 11, 2022
Severe ocular involvement demands inflammation control
April 08, 2022
A team of investigators from Pohang University of Science and Technology has found that conjunctival goblet cell examination is important for the precise diagnosis and effective treatment of ocular surface diseases; however, CGC examination has not been possible until now due to lack of non-invasive devices.
April 02, 2022
Cynthia Matossian, MD, shares her thoughts on the premium patient "experience" or "journey," emphasizing the outcomes of patient experiences.
March 14, 2022
Dongkyun Lang, a biomedical engineering and optical sciences professor, is developing a way to diagnose and treat corneal ulcers that is eight times cheaper and 20 times faster than today's gold standard.
February 25, 2022
Cynthia Matossian, MD, FACS, ABES, points out that there has been confusing news lately about what is (and is not) covered by Medicare when it comes to in-office treatments for meibomian gland dysfunction.
November 14, 2021
Nathan Hall, BS, MS, presents research on how epidemiologic analysis of malignant ocular surface tumors found significant differences in geographic prevalence rates in the United States.
October 22, 2021
Three cases demonstrate value of new tools, technology for surgeons.
October 21, 2021
According to investigators, aqueous humor analysis differentiated the tumors in patients.